Primary sclerosing cholangitis laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 5: Line 5:


==Overview==
==Overview==
The workup in patients with primary sclerosing cholangitis consists of [[LFTs]], [[Immunoglobulin|serum immunoglobulins]], as well as a number of [[autoantibodies]]. Patients with primary sclerosing cholangitis typically have an elevated level of [[ALP]], amongst other findings. However, laboratory results in many patients may be normal.


==Laboratory Findings==
==Laboratory Findings==
The workup in patients with primary sclerosing cholangitis consists of [[LFTs]], [[Immunoglobulins|serum immunoglobulins]], as well as a number of [[autoantibodies]]. Patients with primary sclerosing cholangitis typically have an elevated level of [[ALP]], amongst other findings. However, laboratory results in many patients may be normal.<ref name="pmid27653566">{{cite journal |vauthors=Lazaridis KN, LaRusso NF |title=Primary Sclerosing Cholangitis |journal=N. Engl. J. Med. |volume=375 |issue=12 |pages=1161–70 |year=2016 |pmid=27653566 |doi=10.1056/NEJMra1506330 |url=}}</ref><ref name="pmid20101749">{{cite journal |vauthors=Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ |title=Diagnosis and management of primary sclerosing cholangitis |journal=Hepatology |volume=51 |issue=2 |pages=660–78 |year=2010 |pmid=20101749 |doi=10.1002/hep.23294 |url=}}</ref><ref name="pmid7877651">{{cite journal |vauthors=Lee YM, Kaplan MM |title=Primary sclerosing cholangitis |journal=N. Engl. J. Med. |volume=332 |issue=14 |pages=924–33 |year=1995 |pmid=7877651 |doi=10.1056/NEJM199504063321406 |url=}}</ref><ref name="pmid10707856">{{cite journal |vauthors=Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD |title=Serum autoantibodies in patients with primary sclerosing cholangitis |journal=J. Hepatol. |volume=32 |issue=2 |pages=182–7 |year=2000 |pmid=10707856 |doi= |url=}}</ref><ref name="pmid16879434">{{cite journal |vauthors=Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD |title=Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis |journal=Am. J. Gastroenterol. |volume=101 |issue=9 |pages=2070–5 |year=2006 |pmid=16879434 |doi=10.1111/j.1572-0241.2006.00772.x |url=}}</ref><ref name="pmid16426597">{{cite journal |vauthors=Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T, Toda N, Isayama H, Tada M, Omata M |title=Serum IgG4 concentrations in pancreatic and biliary diseases |journal=Clin. Chim. Acta |volume=367 |issue=1-2 |pages=181–4 |year=2006 |pmid=16426597 |doi=10.1016/j.cca.2005.11.031 |url=}}</ref>
===Liver Function Tests===
Primary sclerosing cholangitis typically has a [[cholestatic]] clinical picture with elevation of [[ALP]], and [[aminotransferases]] ([[AST]] and [[ALT]]) may be elevated to 2-3 times of the upper normal level. However, [[LFTs]] may be normal.
===Immunoglobulins===
*[[Hypergammaglobulinemia]]
*Elevated [[IgM]] levels
*Elevated [[IgG]]4 levels
===Autoantibodies and Serology===
One or more of the following autoantibodies may be present in patients with primary sclerosing cholangitis:
*[[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]])
*[[Anti-nuclear antibody]] ([[ANA]])
*[[Anti-smooth muscle antibody]] ([[Anti smooth muscle antibody|Anti-Sm]])
*Anti-endothelial antibody
*[[Anti-cardiolipin antibodies|Anti-cardiolipin antibody]]
*[[Thyroperoxidase]]
*[[Thyroglobulin]]
*[[Rheumatoid factor]] ([[RF]])


==References==
==References==

Latest revision as of 16:31, 6 December 2017

Primary sclerosing cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary sclerosing cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary sclerosing cholangitis laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary sclerosing cholangitis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary sclerosing cholangitis laboratory findings

CDC on Primary sclerosing cholangitis laboratory findings

Primary sclerosing cholangitis laboratory findings in the news

Blogs on Primary sclerosing cholangitis laboratory findings

Directions to Hospitals Treating Primary sclerosing cholangitis

Risk calculators and risk factors for Primary sclerosing cholangitis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]

Overview

The workup in patients with primary sclerosing cholangitis consists of LFTs, serum immunoglobulins, as well as a number of autoantibodies. Patients with primary sclerosing cholangitis typically have an elevated level of ALP, amongst other findings. However, laboratory results in many patients may be normal.

Laboratory Findings

The workup in patients with primary sclerosing cholangitis consists of LFTs, serum immunoglobulins, as well as a number of autoantibodies. Patients with primary sclerosing cholangitis typically have an elevated level of ALP, amongst other findings. However, laboratory results in many patients may be normal.[1][2][3][4][5][6]

Liver Function Tests

Primary sclerosing cholangitis typically has a cholestatic clinical picture with elevation of ALP, and aminotransferases (AST and ALT) may be elevated to 2-3 times of the upper normal level. However, LFTs may be normal.

Immunoglobulins

Autoantibodies and Serology

One or more of the following autoantibodies may be present in patients with primary sclerosing cholangitis:

References

  1. Lazaridis KN, LaRusso NF (2016). "Primary Sclerosing Cholangitis". N. Engl. J. Med. 375 (12): 1161–70. doi:10.1056/NEJMra1506330. PMID 27653566.
  2. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ (2010). "Diagnosis and management of primary sclerosing cholangitis". Hepatology. 51 (2): 660–78. doi:10.1002/hep.23294. PMID 20101749.
  3. Lee YM, Kaplan MM (1995). "Primary sclerosing cholangitis". N. Engl. J. Med. 332 (14): 924–33. doi:10.1056/NEJM199504063321406. PMID 7877651.
  4. Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD (2000). "Serum autoantibodies in patients with primary sclerosing cholangitis". J. Hepatol. 32 (2): 182–7. PMID 10707856.
  5. Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD (2006). "Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis". Am. J. Gastroenterol. 101 (9): 2070–5. doi:10.1111/j.1572-0241.2006.00772.x. PMID 16879434.
  6. Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T, Toda N, Isayama H, Tada M, Omata M (2006). "Serum IgG4 concentrations in pancreatic and biliary diseases". Clin. Chim. Acta. 367 (1–2): 181–4. doi:10.1016/j.cca.2005.11.031. PMID 16426597.


Template:WikiDoc Sources